Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 14, 2012HaematologicaOpen Access

Lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance, improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial

View Full Paper
Ask AI
Bookmark
Share

Authors

Meletios Α. Dimopoulos
Meletios Α. DimopoulosAlexandra HospitalMDMichel DelforgeCity Of Hope National Medical CenterRHRoman HájekSant Gadge Baba Amravati University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Dimopoulos et al. (2012) studied this question.

synapsesocial.com/papers/6aa93fc1d59caa679c8786ebhttps://doi.org/10.3324/haematol.2012.074534
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Health related quality of life and health status in adult survivors with previously operated complex congenital heart disease2002 · 163 citations
  2. 2Interpreting the significance of changes in health-related quality-of-life scores.1998 · 2,986 citations